Monday, April 10, 2017

IMPT Study Presented at ASTRO Meeting


As a radiation oncologist at Premier Cancer Centers in Dallas, TX, Dr. Rajiv “Raj” Dahiya employs some of the most innovative radiation techniques available to treat cancer patients. In order to stay informed about current industry trends and network with peers, Dr. Raj Dahiya maintains membership in the American Society for Radiation Oncology (ASTRO).

A study introduced during the recent Multidisciplinary Thoracic Cancers Symposium suggests that intensity-modulated proton therapy (IMPT) could help patients with lung cancer, keeping the disease from coming back within a year following the radiation therapy. Using the proton therapy technique, radiation oncologists target cancer cells while leaving normal tissue intact. This therapy is also able to focus on a specific tumor even if it envelops vital organs like the lung.

The average rate of overall survival for those in the study who received IMPT was 18 months. Those who were subject to higher doses experienced even more benefits, as they experienced local failure at only half the rate of the average population and local-regional failure at a quarter of the rate.

No comments:

Post a Comment